Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel; Tim King; James A Daveson; A Daveson; Jane M Andrews; Janakan Krishnarajah; Richard Krause; Gregor J Brown; Ronald Fogel; Charles F Barish; Roger Epstein; Timothy P Kinney; Philip B Miner; Jason A Tye-Din; Adam Girardin; Juha Taavela; Alina Popp; John Sidney; Markku Mäki; Kaela E Goldstein; Patrick H Griffin

doi:10.1016/s2468-1253(17)30110-3

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Gautam Goel
, Tim King
, James A Daveson
, A Daveson
, Jane M Andrews
, Janakan Krishnarajah
, Richard Krause
, Gregor J Brown
, Ronald Fogel
, Charles F Barish
, Roger Epstein
, Timothy P Kinney
, Philip B Miner
, Jason A Tye-Din
, Adam Girardin
, Juha Taavela
, Alina Popp
, John Sidney
, Markku Mäki
, Kaela E Goldstein

Patrick H Griffin

Tutkimustuotos: Artikkeli › Tieteellinen › vertaisarvioitu

135 Sitaatiot (Scopus)

Alkuperäiskieli	Englanti
Sivut	479-493
Julkaisu	The Lancet Gastroenterology and Hepatology
Vuosikerta	2
Numero	7
DOI - pysyväislinkit	https://doi.org/10.1016/s2468-1253(17)30110-3
Tila	Julkaistu - 2017
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Julkaisufoorumi-taso

Jufo-taso 1

Pääsy asiakirjaan

10.1016/s2468-1253(17)30110-3

Siteeraa tätä

Goel, G., King, T., Daveson, J. A., Daveson, A., Andrews, J. M., Krishnarajah, J., Krause, R., Brown, G. J., Fogel, R., Barish, C. F., Epstein, R., Kinney, T. P., Miner, P. B., Tye-Din, J. A., Girardin, A., Taavela, J., Popp, A., Sidney, J., Mäki, M., ... Griffin, P. H. (2017). Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology, 2(7), 479-493. https://doi.org/10.1016/s2468-1253(17)30110-3

@article{c54a190bd87843c390d24170db7081ac,

title = "Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies",

author = "Gautam Goel and Tim King and Daveson, \{James A\} and A Daveson and Andrews, \{Jane M\} and Janakan Krishnarajah and Richard Krause and Brown, \{Gregor J\} and Ronald Fogel and Barish, \{Charles F\} and Roger Epstein and Kinney, \{Timothy P\} and Miner, \{Philip B\} and Tye-Din, \{Jason A\} and Adam Girardin and Juha Taavela and Alina Popp and John Sidney and Markku M{\"a}ki and Goldstein, \{Kaela E\} and Griffin, \{Patrick H\}",

year = "2017",

doi = "10.1016/s2468-1253(17)30110-3",

language = "English",

volume = "2",

pages = "479--493",

journal = "The Lancet Gastroenterology and Hepatology",

issn = "2468-1253",

publisher = "Elsevier Limited",

number = "7",

}

Goel, G, King, T, Daveson, JA, Daveson, A, Andrews, JM, Krishnarajah, J, Krause, R, Brown, GJ, Fogel, R, Barish, CF, Epstein, R, Kinney, TP, Miner, PB, Tye-Din, JA, Girardin, A, Taavela, J , Popp, A, Sidney, J, Mäki, M, Goldstein, KE & Griffin, PH 2017, 'Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies', The Lancet Gastroenterology and Hepatology, Vuosikerta 2, Nro 7, Sivut 479-493. https://doi.org/10.1016/s2468-1253(17)30110-3

TY - JOUR

T1 - Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

AU - Goel, Gautam

AU - King, Tim

AU - Daveson, James A

AU - Daveson, A

AU - Andrews, Jane M

AU - Krishnarajah, Janakan

AU - Krause, Richard

AU - Brown, Gregor J

AU - Fogel, Ronald

AU - Barish, Charles F

AU - Epstein, Roger

AU - Kinney, Timothy P

AU - Miner, Philip B

AU - Tye-Din, Jason A

AU - Girardin, Adam

AU - Taavela, Juha

AU - Popp, Alina

AU - Sidney, John

AU - Mäki, Markku

AU - Goldstein, Kaela E

AU - Griffin, Patrick H

PY - 2017

Y1 - 2017

U2 - 10.1016/s2468-1253(17)30110-3

DO - 10.1016/s2468-1253(17)30110-3

M3 - Article

SN - 2468-1253

VL - 2

SP - 479

EP - 493

JO - The Lancet Gastroenterology and Hepatology

JF - The Lancet Gastroenterology and Hepatology

IS - 7

ER -